HRTL was founded in 2011 as a specialist courier serving the clinical trials industry. The group has since acquired its own licenses to operate in their respective countries and developed strong relationships with local providers, airlines and customs brokers. Each of the group's locations are situated in close proximity to major airports to provide maximum flexibility for expediting time and temperature-sensitive shipments.
The acquisition by Marken will expand its core clinical trials logistics opportunities in central and eastern Europe. Italy, Hungary and Austria are important sources of drug manufacturing, particularly drugs which are manufactured in sterile format. Sterile drug products are particularly sensitive and require specific temperature conditions during transport to ensure stability. Eastern and Central Europe are also important locations for recruitment of clinical trial patients and this acquisition further strengthens Marken's biologic sample services in the region. Marken's hybrid services, which employ the use of UPS' network and airline, will be offered to and from gateway airports in Rome, Milan, Vienna and Budapest.
"The acquisition of this group of companies is an extension of Marken's growth and it satisfies our need for a physical presence in Italy, Austria and Hungary,” said Wes Wheeler, chief executive officer, Marken. “Marken will quickly integrate these three new companies into the Marken network and provide a more robust operating presence in Europe.”